Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study

DOI: 10.1186/s12969-019-0350-5

Keywords: Juvenile localized scleroderma, Comparative effectiveness trial, Study design, Consensus treatment plan, Methotrexate, Corticosteroids, Assessment tools

Full-Text